Gilbert Syndrome and the Development of Antiretroviral Therapy -- Associated Hyperbilirubinemia: Genetic Screening Is Unnecessary
Tags: LETTERS to the editor; ANTIVIRAL agents
Related Articles
- Use of antiretrovirals in newborns. Robinson, Joan L. // CMAJ: Canadian Medical Association Journal;10/28/2003, Vol. 169 Issue 9, p901
Presents a letter to the editor about the use of antiretrovirals in newborns.
- [Five of the authors respond:]. Burdge, David R.; Money, Deborah M.; Forbes, John C.; Samson, Lindy M.; Walmsley, Sharon L. // CMAJ: Canadian Medical Association Journal;10/28/2003, Vol. 169 Issue 9, p901
Presents a response to a letter to the editor about the use of antiretrovirals in newborns.
- Reply to Agrati et al. Abate, Getahun; Eslick, Joy; Newman, Frances K.; Frey, Sharon E.; Belshe, Robert B.; Monath, Thomas P.; Hoft, Daniel F. // Journal of Infectious Diseases;6/1/2006, Vol. 193 Issue 11, p1607
A letter to the editor is presented in response to the article titled "Interferon-Mediated Antiviral Immunity Against Orthopoxvirus Infection Is Provided by T cells," by C. Agrati, C. Castiletti and R. De Santis, published in a 2006 issue of the "Journal of Infectious Diseases."
- Reply to Nettles et al. Telenti, Amalio // Journal of Infectious Diseases;6/1/2006, Vol. 193 Issue 11, p1612
A letter to the editor is presented in response to the article titled "Gilbert Syndrome and the Development of Antiretroviral Therapy-Associated Hyperbilirubineia: Genetic Screening is Unnecessary," by R.E. Nettles, M.J. Child and R.J. Bertz, published in a 2006 issue of the "Journal of...
- Impact of Antituberculosis Treatment on Virological Response to Highly Active Antiretroviral Therapy: Implications for Resource-Limited Settings? Lawn, Stephen D.; Wood, Robin // Journal of Infectious Diseases;11/15/2006, Vol. 194 Issue 10, p1467
A letter to the editor is presented in response to the article "Virological Response to Highly Active Antiretroviral Therapy Is Unaffected by Antituberculosis Therapy," by R. A. M. Breen, R. F. Miller, T. Gorsuch and colleagues in 2006 issue is presented.
- Reply to Lawn and Wood. Breen, Ronan A. M.; Miller, R. F.; Gorsuch, T.; Smith, C. J.; Ainsworth, J.; Ballinger, J.; Swaden, L.; Cropley, I.; Johnson, M. A.; Lipman, M. C. I. // Journal of Infectious Diseases;11/15/2006, Vol. 194 Issue 10, p1468
A response by R. A. M. Breen, R. F. Miller, T. Gorsuch and colleagues to a letter to the editor about their article "Virological Response to Highly Active Antiretroviral Therapy Is Unaffected by Antituberculosis Therapy" in 2006 issue is presented.
- Protease Inhibitor--Associated Increased Risk of Preterm Delivery Is an Immunological Complication of Therapy. Fiore, Simona; Ferrazzi, Enrico; Newell, Marie-Louise; Trabattoni, Daria; Clerici, Mario // Journal of Infectious Diseases;3/15/2007, Vol. 195 Issue 6, p914
A letter to the editor about the associated obstetrical risks of antiretroviral therapy is presented.
- Tolerance of Didanosine as Enteric-Coated Capsules versus Buffered Tablets. Barreiro, Pablo; Corbat�n, Arturo; N��ez, Marina; Gonz�lez-Lahoz, Juan; Soriano, Vincent // AIDS Patient Care & STDs;Jun2004, Vol. 18 Issue 6, p329
Presents a letter to the editor about the tolerance of didanosine, a nucleoside analogue that inhibits the HIV reverse transcriptase enzyme.
- Induction Therapy with Enfuvirtide-Based Highly Active Antiretroviral Therapy in A Patient with Acute HIV-1 Infection. Polk, Christopher; Chan-Tack, Kirk M.; Kopack, Angela M.; Amoroso, Anthony // AIDS Patient Care & STDs;Feb2007, Vol. 21 Issue 2, p75
A letter to the editor is presented discussing "Induction Therapy with Enfuvirtide-Based Highly Active Antiretroviral Therapy in A Patient with Acute HIV-1 Infection."
